Leadership to Enhance Aging Research and Innovation in Medical Culture (LEARN-MC)

领导力加强医学文化中的老龄化研究和创新(LEARN-MC)

基本信息

项目摘要

Project Abstract/Summary There is currently no known prevention, cure, or effective treatment for Alzheimer’s disease and related dementia (ADRD) even as the number of people with ADRD is projected to increase dramatically as the population ages. Policymakers, advocates, clinicians, patients, and caregivers have asked the research community to improve our understanding of the cultural dynamics surrounding ADRD in order to develop effective, evidence-based, and sustainable approaches for caring for ADRD-impacted populations. The premise of this application is that there is a need for increased research capacity to advance our understanding of culture, aging, and ADRD and help address the challenge presented by the increasing prevalence of Alzheimer’s and related dementias. This application for an Academic Leadership Award is entitled Leadership to Enhance Aging Research and iNnovation in Medical Culture (LEARN-MC). It aims to enhance the capacity of the University of California San Francisco (UCSF) to conduct research on aging and medical culture in the context of ADRD. LEARN-MC will be based in the UCSF Medical Cultures Lab (MCL). It reflects the PI’s training in sociology of culture and ethnography, his research track record on medical culture, and his experience developing educational and training programs. LEARN-MC will build on and expand on existing relationships with multiple communities conducting ADRD research at UCSF including the Departments of Neurology and Surgery, Divisions of Geriatrics and Palliative Medicine, and the Global Brain Health Institute. LEARN-MC has three specific aims. Aim 1: Create and maintain a resource library that synthesizes scholarship on medical culture, aging, and ADRD from anthropology, geriatrics, gerontology, sociology, and related fields. Aim 2: Develop courses on medical culture, ADRD, and aging to be taught in coordination with existing UCSF teaching and training programs to learners at diverse career stages. Aim 3: Establish the Medical Cultures Lab (MCL) as a center of excellence for research on medical culture, aging, and ADRD. Expand MCL’s role as a mentorship hub for aging and ADRD research at UCSF. Use public events and social media to establish MCL as a thought leader among policymakers, healthcare professionals, and the lay public.
项目摘要/摘要 目前还没有已知的预防、治愈或有效治疗阿尔茨海默病和相关疾病的方法 痴呆症(ADRD),尽管ADRD的人数预计将随着 人口老龄化。政策制定者、倡导者、临床医生、患者和护理人员要求进行这项研究 社区提高我们对围绕ADRD的文化动态的了解,以便发展 有效、以证据为基础和可持续的方法来照顾受ADRD影响的人群。这个 这一应用的前提是需要增加研究能力来促进我们的理解 文化、老龄化和ADRD,并帮助应对日益普遍的 阿尔茨海默氏症和相关痴呆症。 这份学术领导力奖的申请书名为《加强老龄化研究的领导力》 医学文化创新(学习-MC)。它的目的是增强加州大学旧金山分校的能力 旧金山(加州大学旧金山分校)在ADRD的背景下进行老龄化和医学文化的研究。学习-MC将 总部设在加州大学旧金山分校医学培养实验室(MCL)。它反映了少年派在文化和社会学方面的训练 民族志,他在医学文化方面的研究记录,以及他发展教育和 培训计划。学习-MC将在与多个社区的现有关系基础上进行构建和扩展 在加州大学旧金山分校进行ADRD研究,包括神经科和外科, 老年学和姑息医学,以及全球脑健康研究所。学习-MC有三个具体目标。 目标1:创建和维护一个综合了医学文化、老龄化和 ADRD来自人类学、老年学、老年学、社会学及相关领域。 目标2:开发关于医学文化、ADRD和老龄化的课程,与现有的加州大学旧金山分校合作教授 为处于不同职业阶段的学习者提供教学和培训计划。 目标3:建立医学文化实验室(MCL),作为医学文化研究的卓越中心, 衰老和ADRD。扩大MCL作为加州大学旧金山分校老龄化和ADRD研究导师中心的角色。使用公共 活动和社交媒体,使MCL成为政策制定者、医疗保健专业人员、 以及非专业人士。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Daniel P. Dohan其他文献

Daniel P. Dohan的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Daniel P. Dohan', 18)}}的其他基金

Leadership to Enhance Aging Research and Innovation in Medical Culture (LEARN-MC)
领导力加强医学文化中的老龄化研究和创新(LEARN-MC)
  • 批准号:
    10427360
  • 财政年份:
    2020
  • 资助金额:
    $ 13.5万
  • 项目类别:
Leadership to Enhance Aging Research and Innovation in Medical Culture (LEARN-MC)
领导力加强医学文化中的老龄化研究和创新(LEARN-MC)
  • 批准号:
    10224096
  • 财政年份:
    2020
  • 资助金额:
    $ 13.5万
  • 项目类别:
Next-Gen ethnography to understand decision-making among diverse populations impacted by Alzheimer's disease and related dementias (ADRD)
下一代民族志可了解受阿尔茨海默病和相关痴呆症 (ADRD) 影响的不同人群的决策
  • 批准号:
    10093953
  • 财政年份:
    2020
  • 资助金额:
    $ 13.5万
  • 项目类别:
Next-Gen ethnography to understand decision-making among diverse populations impacted by Alzheimer'sdisease and related dementias (ADRD)
下一代民族志可了解受阿尔茨海默病和相关痴呆症 (ADRD) 影响的不同人群的决策
  • 批准号:
    10582973
  • 财政年份:
    2020
  • 资助金额:
    $ 13.5万
  • 项目类别:
Before Consent: Cancer Patients' Deliberations about Early Phase Clinical Trials
同意之前:癌症患者对早期临床试验的考虑
  • 批准号:
    8658026
  • 财政年份:
    2010
  • 资助金额:
    $ 13.5万
  • 项目类别:
Before Consent: Cancer Patients' Deliberations about Early Phase Clinical Trials
同意之前:癌症患者对早期临床试验的考虑
  • 批准号:
    8256596
  • 财政年份:
    2010
  • 资助金额:
    $ 13.5万
  • 项目类别:
Before Consent: Cancer Patients' Deliberations about Early Phase Clinical Trials
同意之前:癌症患者对早期临床试验的考虑
  • 批准号:
    8450179
  • 财政年份:
    2010
  • 资助金额:
    $ 13.5万
  • 项目类别:
Before Consent: Cancer Patients' Deliberations about Early Phase Clinical Trials
同意之前:癌症患者对早期临床试验的考虑
  • 批准号:
    8080846
  • 财政年份:
    2010
  • 资助金额:
    $ 13.5万
  • 项目类别:
Poverty, Substance Use, and Stigma in Four Organizations
四个组织中的贫困、药物滥用和耻辱
  • 批准号:
    6941393
  • 财政年份:
    2003
  • 资助金额:
    $ 13.5万
  • 项目类别:
Poverty, Substance Use, and Stigma in Four Organizations
四个组织中的贫困、药物滥用和耻辱
  • 批准号:
    6681800
  • 财政年份:
    2003
  • 资助金额:
    $ 13.5万
  • 项目类别:

相似海外基金

Optimizing Health and Well-Being of Diverse Mothers with IDD and Their Infants During the Perinatal Period: A Virtual Advocate Tool for Data-Driven Supports
优化患有 IDD 的不同母亲及其婴儿在围产期的健康和福祉:用于数据驱动支持的虚拟倡导工具
  • 批准号:
    10760051
  • 财政年份:
    2023
  • 资助金额:
    $ 13.5万
  • 项目类别:
POSE: Phase II: Advocate Led Long-term Gameplan for Open OnDemand (ALL GOOD)
POSE:第二阶段:倡导者主导 Open OnDemand 的长期游戏计划(一切顺利)
  • 批准号:
    2303692
  • 财政年份:
    2023
  • 资助金额:
    $ 13.5万
  • 项目类别:
    Standard Grant
Capitalising on our differences: A gathering to better understand and advocate for Early Career Health Researchers in Canada
利用我们的差异:更好地理解和倡导加拿大早期职业健康研究人员的聚会
  • 批准号:
    468168
  • 财政年份:
    2022
  • 资助金额:
    $ 13.5万
  • 项目类别:
    Miscellaneous Programs
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
  • 批准号:
    10427960
  • 财政年份:
    2022
  • 资助金额:
    $ 13.5万
  • 项目类别:
Evaluating an ACEs-Targeting Advocate Model of a Substance Use Prevention Program
评估药物使用预防计划的针对 ACE 的倡导者模型
  • 批准号:
    10577074
  • 财政年份:
    2022
  • 资助金额:
    $ 13.5万
  • 项目类别:
The Art of Creation: Using Art-Based Knowledge Translation to Promote and Advocate for a Healthy Start to Life
创造的艺术:利用基于艺术的知识转化来促进和倡导健康的生命开端
  • 批准号:
    486588
  • 财政年份:
    2022
  • 资助金额:
    $ 13.5万
  • 项目类别:
    Studentship Programs
When I am Old, I shall Wear Purple Nail Varnish: Utilising performance art to construct queer spaces that celebrate and advocate for ageing bodies
当我老了,我要涂紫色指甲油:利用行为艺术构建酷儿空间,庆祝和倡导衰老的身体
  • 批准号:
    2760091
  • 财政年份:
    2022
  • 资助金额:
    $ 13.5万
  • 项目类别:
    Studentship
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
  • 批准号:
    10621188
  • 财政年份:
    2022
  • 资助金额:
    $ 13.5万
  • 项目类别:
Techquity by FAITH!: A cluster randomized controlled trial to assess the efficacy of a community-informed, cardiovascular health promotion mobile hlth intervention with digital health advocate support
Techquity by FAITH!:一项整群随机对照试验,旨在评估社区知情、心血管健康促进移动 hlth 干预措施在数字健康倡导者支持下的效果
  • 批准号:
    10891016
  • 财政年份:
    2021
  • 资助金额:
    $ 13.5万
  • 项目类别:
CMV responses in autoantibody positive subjects advocate antiviral treatments for prevention of T1D
自身抗体阳性受试者的 CMV 反应主张抗病毒治疗以预防 T1D
  • 批准号:
    10230365
  • 财政年份:
    2020
  • 资助金额:
    $ 13.5万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了